Acute Kidney Dysfunction in Cirrhosis: Diagnosis, Drugs, and Dialysis

Concurrent Session Moderator(s)

• 

  Katherine McCusker, ARNP

  University of Washington

  Disclosure(s): No relevant financial relationship(s) to disclose.

Acute kidney dysfunction is common in patients with cirrhosis. Differentiating hepatorenal syndrome/acute kidney injury from other forms of kidney dysfunction in liver disease is challenging. The session will discuss how to navigate the use of biopsy and biomarkers and apply standard criteria to parse the nature of the syndrome. The numerous available interventions (albumin, octreotide, midodrine, norepinephrine, terlipressin) will be discussed, with a focus on which drug to choose for which patient and practical considerations such as dosing, formulary, access, and transitions of care. The choice of introducing dialysis with reconciliation of prognosis, transplant candidacy, and modality options will also be discussed.

Presentations:

• 11:50 AM - 12:05 PM Central Time

  Differentiating Disease: Separating Causes of Acute Kidney Dysfunction in Cirrhosis
  

  Marlies Ostermann, PhD, , MD, EDIC (she/her/hers) – Guy's and St Thomas' NHS Foundation Trust
• 12:05 PM - 12:20 PM Central Time

  Which Drugs for Which Patient? A Myriad of Choices to Treat Kidney Dysfunction in Cirrhosis
  

  Heather May, BCCCP, PharmD, FCCM – Mayo Clinic
• 12:20 PM - 12:35 PM Central Time

  Bridge to Nowhere? Key Considerations With Dialysis in Cirrhosis
  

  Kathleen Liu, MD, PhD, – University of California San Francisco Medical Center